ArticleBMC gastroenterology2026

Real-world utility of platelet count, hemoglobin, and iron levels as predictors of clinical response to vedolizumab in patients with ulcerative colitis: a retrospective, single-center study in Poland.

Aleksandra Sobolewska-Włodarczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.